IP Library Granted Patent US 9,044,458
Granted Patent B2
US 9,044,458 · App. 13/816,334 · Granted Jun 2, 2015

Inhibition of tat activating regulatory DNA-binding protein 43

Inventors: Philip C. Wong (Lutherville, MD); Donald L. Price (Columbia, MD); Po-Min Chiang (Tainan, TW)
Assignee: The Johns Hopkins University
A61K39/3955A61K31/00A61K31/7088C07K14/4702C12Q1/6883C12Q2600/158G01N33/6893G01N2333/4703G01N2800/044C12Q2600/136A61K31/7105A61K31/713
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,044,458
App. No.
13/816,334
Granted
Jun 2, 2015
Kind
B2
Abstract

Described herein are methods for detecting, characterizing, preventing, and treating metabolic diseases, including obesity and obesity-associated disorders such as diabetes.

Claims (17)

1. A method for reducing body fat mass in a subject, the method comprising administering to the subject an oligonucleotide molecule that inhibits the expression of Tat activating regulatory DNA-binding protein 43 (TDP-43) to thereby reduce body fat mass in the subject.

2. The method of claim 1 , wherein the subject further has a decreased respiratory exchange ratio.

3. The method of claim 1 , wherein the subject further has increased fat oxidation.

4. The method of claim 1 , wherein the subject further has weight loss.

5. The method of claim 1 , wherein the body fat mass is whole body fat mass.

6. The method of claim 1 , wherein the oligonucleotide is an antisense oligonucleotide that binds to mRNA encoding TDP-43.

7. The method of claim 1 , wherein the oligonucleotide is an siRNA specific for TDP-43.

8. The method of claim 1 , wherein the oligonucleotide is an shRNA specific for TDP-43.

9. A method for reducing body fat mass in a subject, the method comprising administering to the subject an agent that: (i) binds to Tat activating regulatory DNA-binding protein 43 (TDP-43) and (ii) inhibits the ability of TDP-43 to regulate a TDP-43 regulated gene, to thereby reduce body fat mass in the subject.

10. The method of claim 9 , wherein the agent is a small molecule.

11. The method of claim 9 , wherein the agent is a nucleic acid.

12. The method of claim 9 , wherein the agent is an anti-TDP-43 antibody or a non-activating form of TDP-43 polypeptide or fragment thereof.

13. The method of claim 9 , wherein the subject is a human.

14. The method of claim 9 , wherein the subject further has a decreased respiratory exchange ratio.

15. The method of claim 9 , wherein the subject further has increased fat oxidation.

16. The method of claim 9 , wherein the subject further has weight loss.

17. The method of claim 9 , wherein the body fat mass is whole body fat mass.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2013
From: WONG, PHILIP C.; PRICE, DONALD L.; CHIANG, PO-MIN
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 030448/0075 →
Continuity (2)
Provisional Application 61371825 · Aug 9, 2010
Related Publication 20130219534A1 · Aug 22, 2013